Funded Tech Companies

Avidimer Therapeutics

Headquartered in Tecumseh, Avidimer Therapeutics has funding from Flagship Pioneering and North Coast Technology Investors.

Company Overview

Company Name
Avidimer Therapeutics
Company Status
Out of Business
Funding Rounds

Contact Information

Mailing Address
130 W. Chicago Blvd.
Tecumseh, MI 49286
USA
Email Address

Company Background Information

Overview
Avidimer Therapeutics develops and commercializes pharmaceuticals, called avidimers, based on proprietary nanotechnology. Avidimers are 'smart drugs' designed to maximize damage to disease targets while minimizing collateral damage to healthy tissue. The initial focus of the company is on cancer detection and treatment.
Profile
Avidimer Therapeutics LinkedIn Company Profile
Social Media
Avidimer Therapeutics Company Twitter Account
Company News
Avidimer Therapeutics News
Facebook
Avidimer Therapeutics on Facebook
YouTube
Avidimer Therapeutics on YouTube
Last Transaction
9/30/2007

Financing History

Date
Type
Amount
Venture Equity
$2,514,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Larry Sternson
  Larry Sternson LinkedIn Profile  Larry Sternson Twitter Account  Larry Sternson News  Larry Sternson on Facebook
Chief Scientific Officer
James Baker
  James Baker LinkedIn Profile  James Baker Twitter Account  James Baker News  James Baker on Facebook
VP - Bus. Development
David Repp
  David Repp LinkedIn Profile  David Repp Twitter Account  David Repp News  David Repp on Facebook
VP - Regulatory Affairs
Deborah Ladenheim
  Deborah Ladenheim LinkedIn Profile  Deborah Ladenheim Twitter Account  Deborah Ladenheim News  Deborah Ladenheim on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Avidia | Avidity Biosciences

 

Share this article

 


About Our Venture Capital Transactions Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary